An operator teardown of a vendor-reported hospital denial program that tested 25 cases before scaling to a reported $40 million recovery.
R1 reports that a large hospital recovered $293,000 from a 25-case denial pilot and later recovered $40 million across 9,234 cases during the first year of a broader program. The numbers are vendor-reported, not an Elevate Revenue Group result or an independently audited outcome. The operational lesson is still useful: the hospital tested a closure assumption on a focused sample before it scaled the workflow.
What the public case reports
The case describes a hospital with more than $1 billion in net patient revenue and more than 34,000 annual discharges. Its internal team believed certain diagnosis-related group denials were not worth appealing and downgraded them when the denial arrived.
A pilot reviewed 25 cases that otherwise would have been closed. R1 reports that those cases produced $293,000 in recovery. After the program expanded, 9,234 cases were referred and $40 million was recovered in the first year.
Those figures should be attributed to the source. They are not evidence that every denial should be appealed or that another organization will reproduce the same recovery.
The operating failure was an untested closure rule
The main problem was not simply the wording of an appeal. A high-value category had been labeled uneconomic before the recoverability assumption was tested. That kind of rule can become invisible when teams measure only closed inventory, productivity, or gross denial volume.
A disciplined pilot creates a better decision. Select claims the team normally closes, preserve the payer's exact reason, capture the clinical and coding evidence, protect the filing deadline, and record recovered dollars, turnaround time, work effort, and root cause.
Use the remittance and deadline as controls
CMS explains that an electronic or standard remittance advice uses Group Codes, Claim Adjustment Reason Codes, and Remittance Advice Remark Codes to describe adjustments. Those fields should remain attached to the case rather than being reduced to a generic denial label.
For Medicare fee-for-service redeterminations, CMS says the request generally must be filed within 120 days of receiving the initial determination. Commercial, Medicaid, and other payer deadlines can differ, so the actual contract and program rules must control each work queue.
The practical takeaway
The useful lesson is not “appeal everything.” It is “do not scale opinion.” Run a focused sample, measure the economics, identify the categories with defensible recovery, and send recurring causes back to clinical, coding, authorization, and contracting owners.
A recovery program is strongest when it returns cash and changes the upstream process that created the denial. The first metric should be the evidence from the pilot; the long-term metric should include prevention.
Practical takeaway
Test the denials your team routinely closes before accepting that they are not worth appealing.
Preserve payer reason codes, evidence, ownership, and filing deadlines for every sampled case.
Scale a recovery workflow only after the sample proves the economics and reveals upstream causes.